This explains why factors that inhibit CD73 activity depress cell proliferation and vice versa (Andree et al., 1987; Bavaresco et al., 2008), which represent the basis for new and promising therapeutic options for cancer treatment (Antonioli et al., 2016). This evidence concerns the gene NT5E and cancer.